Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women

NCT00961272 · clinicaltrials.gov ↗
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Kristine Patterson, MD

Collaborators